Antiplatelet agents and anticoagulants for hypertension

Overview of attention for article published in Cochrane database of systematic reviews, December 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 15,785 followers.

Prevención de IAM con AAS en HTA tiene = beneficio (NNT 200) que riesgo hemorrágico (NNH 154) [Cochrane Syst Rev. 2011] http://t.co/CxfBRwCU

Større skade end gavn ved brug af ASA ved hypertension uden tidl. thrombotisk sygdom. @cochranecollab http://t.co/fyjLq7TU

Antiplatelet agents and anticoagulants for hypertension.: CONCLUSIONS: Antiplatelet therapy with ASA for primary... http://t.co/EonA704L

RT @CochraneHTN: Updated #Cochrane systematic review: Antiplatelet agents and anticoagulants for #hypertension: http://t.co/WmSHSwJx #ebm

Updated #Cochrane systematic review: Antiplatelet agents and anticoagulants for #hypertension: http://t.co/WmSHSwJx #ebm